Bringing molecular prognosis and prediction to the clinic.

doi:10.3816/CBC.2005.n.010

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Bringing molecular prognosis and prediction to the clinic.

Clinical breast cancer - 1 Apr 2005

Colozza Mariantonietta, Cardoso Fatima, Sotiriou Christos, Larsimont Denis, Piccart Martine J

Abstract excerpt

In the past 30 years, important advances have been made in the knowledge of breast cancer biology and in the treatment of the disease. However, the translation of these advances into clinical practice has been slow. With the advent of molecular-based medicine, it is hoped that the bridge between the bench and the bedside will continue to be shortened. Because breast cancer is a heterogeneous disease with...

Topics

Adult
Aged
Biomarkers, Tumor
Breast Neoplasms
Combined Modality Therapy
Cyclin E
Female
Gene Expression Regulation, Neoplastic
Genetic Predisposition to Disease
Humans
Middle Aged
Molecular Biology
Neoplasm Staging
Predictive Value of Tests
Prognosis
Receptor, ErbB-2
Receptors, Estrogen
Risk Assessment

Source

Open in PubMed

Identifiers

PMID: 15899074
DOI: 10.3816/CBC.2005.n.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics